Assessment of Abuse Potential of Cebranopadol in Humans

Clinical trial NCT05256108 · COMPLETED

Trial details

NCT number: NCT05256108
Sponsor: Tris Pharma, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Human Abuse Potential

Start date: 2022-03-28
Primary completion: 2022-07-12
Enrollment: 38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.